Annual FCF
-$24.23 M
+$3.48 M+12.56%
December 31, 2023
Summary
- As of February 12, 2025, MBRX annual free cash flow is -$24.23 million, with the most recent change of +$3.48 million (+12.56%) on December 31, 2023.
- During the last 3 years, MBRX annual FCF has fallen by -$6.08 million (-33.49%).
- MBRX annual FCF is now -539.86% below its all-time high of -$3.79 million, reached on December 31, 2016.
Performance
MBRX Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$6.11 M
-$151.00 K-2.53%
September 30, 2024
Summary
- As of February 12, 2025, MBRX quarterly free cash flow is -$6.11 million, with the most recent change of -$151.00 thousand (-2.53%) on September 30, 2024.
- Over the past year, MBRX quarterly FCF has increased by +$604.00 thousand (+8.99%).
- MBRX quarterly FCF is now -2007.93% below its all-time high of -$290.00 thousand, reached on March 31, 2016.
Performance
MBRX Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$24.28 M
+$1.47 M+5.69%
September 30, 2024
Summary
- As of February 12, 2025, MBRX TTM free cash flow is -$24.28 million, with the most recent change of +$1.47 million (+5.69%) on September 30, 2024.
- Over the past year, MBRX TTM FCF has increased by +$645.00 thousand (+2.59%).
- MBRX TTM FCF is now -8272.41% below its all-time high of -$290.00 thousand, reached on March 31, 2016.
Performance
MBRX TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
MBRX Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +12.6% | +9.0% | +2.6% |
| 3 y3 years | -33.5% | -18.9% | +6.6% |
| 5 y5 years | -92.0% | -18.9% | +6.6% |
MBRX Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -27.7% | +12.6% | -43.6% | +24.2% | -28.1% | +16.0% |
| 5 y | 5-year | -40.4% | +12.6% | -94.7% | +24.2% | -40.8% | +16.0% |
| alltime | all time | -539.9% | +12.6% | -2007.9% | +24.2% | -8272.4% | +16.0% |
Moleculin Biotech Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$6.11 M(+2.5%) | -$24.28 M(-5.7%) |
| Jun 2024 | - | -$5.96 M(-11.2%) | -$25.75 M(+3.3%) |
| Mar 2024 | - | -$6.72 M(+22.4%) | -$24.93 M(+2.9%) |
| Dec 2023 | -$24.23 M(-12.6%) | -$5.49 M(-27.6%) | -$24.23 M(-6.8%) |
| Sep 2023 | - | -$7.58 M(+47.4%) | -$25.99 M(+0.0%) |
| Jun 2023 | - | -$5.14 M(-14.6%) | -$25.99 M(-10.1%) |
| Mar 2023 | - | -$6.02 M(-17.1%) | -$28.91 M(+4.4%) |
| Dec 2022 | -$27.71 M(+46.1%) | -$7.26 M(-4.2%) | -$27.71 M(+12.1%) |
| Sep 2022 | - | -$7.58 M(-6.0%) | -$24.71 M(+15.4%) |
| Jun 2022 | - | -$8.06 M(+67.6%) | -$21.42 M(+6.4%) |
| Mar 2022 | - | -$4.81 M(+13.0%) | -$20.14 M(+6.3%) |
| Dec 2021 | -$18.97 M(+4.5%) | -$4.26 M(-0.7%) | -$18.95 M(+6.3%) |
| Sep 2021 | - | -$4.29 M(-36.8%) | -$17.83 M(-7.4%) |
| Jun 2021 | - | -$6.78 M(+87.1%) | -$19.26 M(+10.5%) |
| Mar 2021 | - | -$3.62 M(+15.4%) | -$17.43 M(-4.0%) |
| Dec 2020 | -$18.15 M | -$3.14 M(-45.0%) | -$18.15 M(-7.9%) |
| Sep 2020 | - | -$5.71 M(+15.4%) | -$19.69 M(+13.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2020 | - | -$4.95 M(+14.0%) | -$17.32 M(-2.3%) |
| Mar 2020 | - | -$4.34 M(-7.3%) | -$17.73 M(+2.8%) |
| Dec 2019 | -$17.25 M(+36.7%) | -$4.69 M(+40.5%) | -$17.25 M(+9.3%) |
| Sep 2019 | - | -$3.33 M(-37.8%) | -$15.79 M(+1.4%) |
| Jun 2019 | - | -$5.37 M(+38.9%) | -$15.57 M(+13.9%) |
| Mar 2019 | - | -$3.86 M(+19.8%) | -$13.67 M(+8.3%) |
| Dec 2018 | -$12.62 M(+71.7%) | -$3.22 M(+3.5%) | -$12.62 M(+6.9%) |
| Sep 2018 | - | -$3.11 M(-10.2%) | -$11.80 M(+14.5%) |
| Jun 2018 | - | -$3.47 M(+23.2%) | -$10.31 M(+17.4%) |
| Mar 2018 | - | -$2.81 M(+17.0%) | -$8.78 M(+19.4%) |
| Dec 2017 | -$7.35 M(+94.2%) | -$2.41 M(+48.6%) | -$7.35 M(+20.0%) |
| Sep 2017 | - | -$1.62 M(-16.4%) | -$6.13 M(+12.0%) |
| Jun 2017 | - | -$1.94 M(+39.2%) | -$5.47 M(+11.9%) |
| Mar 2017 | - | -$1.39 M(+17.9%) | -$4.89 M(+29.1%) |
| Dec 2016 | -$3.79 M | -$1.18 M(+22.8%) | -$3.79 M(+45.3%) |
| Sep 2016 | - | -$961.00 K(-29.1%) | -$2.61 M(+58.4%) |
| Jun 2016 | - | -$1.35 M(+367.2%) | -$1.65 M(+467.2%) |
| Mar 2016 | - | -$290.00 K | -$290.00 K |
FAQ
- What is Moleculin Biotech annual free cash flow?
- What is the all time high annual FCF for Moleculin Biotech?
- What is Moleculin Biotech annual FCF year-on-year change?
- What is Moleculin Biotech quarterly free cash flow?
- What is the all time high quarterly FCF for Moleculin Biotech?
- What is Moleculin Biotech quarterly FCF year-on-year change?
- What is Moleculin Biotech TTM free cash flow?
- What is the all time high TTM FCF for Moleculin Biotech?
- What is Moleculin Biotech TTM FCF year-on-year change?
What is Moleculin Biotech annual free cash flow?
The current annual FCF of MBRX is -$24.23 M
What is the all time high annual FCF for Moleculin Biotech?
Moleculin Biotech all-time high annual free cash flow is -$3.79 M
What is Moleculin Biotech annual FCF year-on-year change?
Over the past year, MBRX annual free cash flow has changed by +$3.48 M (+12.56%)
What is Moleculin Biotech quarterly free cash flow?
The current quarterly FCF of MBRX is -$6.11 M
What is the all time high quarterly FCF for Moleculin Biotech?
Moleculin Biotech all-time high quarterly free cash flow is -$290.00 K
What is Moleculin Biotech quarterly FCF year-on-year change?
Over the past year, MBRX quarterly free cash flow has changed by +$604.00 K (+8.99%)
What is Moleculin Biotech TTM free cash flow?
The current TTM FCF of MBRX is -$24.28 M
What is the all time high TTM FCF for Moleculin Biotech?
Moleculin Biotech all-time high TTM free cash flow is -$290.00 K
What is Moleculin Biotech TTM FCF year-on-year change?
Over the past year, MBRX TTM free cash flow has changed by +$645.00 K (+2.59%)